Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.

Cardiovascular M & A Deals
Advertisement

Companies

Set Alert for Companies

Latest From Companies

Medtech Money Flow: M&A & VC Deals, Jan. 7-13, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Jan. 7-13, 2019.

M & A Financing

GE Healthcare Forges Five-Year Precision Medicine Partnership With Vanderbilt

GE Healthcare is making a bid to become the leader in precision medicine by collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care.

Artificial Intelligence Personalized Medicine

Nexstim Targets Canadian Market With New Distributor Agreement

Neuromodulation firm Nexstim will launch its SmartFocus TMS system for treating major depressive disorder (MDD) in Canada after signing an exclusive agreement with distributor Canada Health Solutions CHS.

Canada Deals
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Device Week, Jan. 18, 2019 - Key Topics At This Year's JP Morgan Healthcare Conference

On this week's podcast, Medtech Insight's Catherine Longworth chats with Marion Webb about some key takeaways from this year's JP Morgan Healthcare Conference. That includes a Q&A with Smith & Nephew's new CEO Namal Nawana on his growth strategy for the British medtech giant, new partnership announcements between medtech and tech companies, and trends in digital health.

Device Week Deals

Medtech Money Flow: M&A & VC Deals, Jan. 7-13, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Jan. 7-13, 2019.

M & A Financing

QUOTED. Jan. 11, 2019. Ben Newton.

GE Healthcare is collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care. Ben Newton, GE Healthcare's chief digital officer, explained that GE hopes the partnership will help GE become a leader in precision medicine by developing algorithms and artificial intelligence systems that can predict adverse events in cancer patients.

Quoted Deals
See All

Market Access

Set Alert for Market Access

Latest From Market Access

Device Week, Jan. 11, 2019 – A New Plan From NHS In A Period Of UK Uncertainty

On this week's podcast, Ashley Yeo talks about the "Long Term Plan" published by the UK's National Health Service this week, and the implications of Brexit.

Device Week United Kingdom

Lawsuit Seeks Expanded Medicare Reimbursement For CGM

A law firm has filed a class action suit against the US Department of Health and Human Services trying to force broader Medicare reimbursement of continuous glucose monitors. Currently, federal health programs will only cover specific types and uses of the diabetes treatment technology.

Legal Issues Reimbursement

QUOTED. Jan. 9, 2019. Niall Dickson.

The UK's National Health Service issued a long-anticipated plan this week outlining significant structural changes it envisions for the country's health-care system. Niall Dickson, who heads the NHS Confederation, says it is high time for changes in how NHS and industry work together.

Quoted Market Access
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Snapshot: Flow Diversion Sees Highest Growth Among Neurointerventional Embolization Systems

Our infographic spotlights key trends in the global market for cerebral aneurysm and arteriovenous malformation (AVM) embolization systems, which is expected to reach $1.2bn by 2022, a CAGR of 3.9% from $975m in 2017. Among the growth drivers is the improvement of imaging screening techniques in developed nations. While this has resulted in increased intervention for cerebral aneurysm and AVM embolization, routine screening is not practiced, even in developed nations. Embolic coils accounted for the majority of sales with an estimated 73% market share. Meanwhile, a growing number of improved and premium-priced products such coil-assisted stent products and advanced embolic coil designs and flow diversion products are driving up the total value of the market.

Commercial Market Intelligence

Market Intel 2018: Hemodialysis, MIGs And Liquid Biopsy Make Waves

A look back at the five most-read Market Intelligence features of 2018 reveals a diverse mix of interests by our readers hemodialysis, ophthalmic surgical solutions, liquid biopsy, digital solutions for diabetes management and a futuristic look at robotic pills to deliver drugs.

Commercial Market Intelligence

Device Week, Dec. 13, 2018 – Physicians Offer Perspective On Diabetes Apps; Researchers Apply Cancer Radiation To Cardiac Arrhythmia

In this edition of Device Week, Medtech Insight’s weekly podcast, Marion Webb gives an overview of physicians’ perspective of digital apps for diabetes patients and Reed Miller discusses the early research into a potentially promising non-invasive radiation technique for treating ventricular tachycardia.

Device Week Market Intelligence
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: Shockwave, Natera Updates

Prenatal testing firm Natera appoints a new chief operating officer and interventional cardiovascular device firm Shockwave Medical seats a new board chairman, among recent medtech and biotech personnel moves.

Appointments Commercial

Execs On The Move: C-Suite Developments At Beltone, ImaginAb And Ra Medical

This week, a new president at otolaryngology device firm Beltone, plus a chief business officer comes on board at immune and oncology imaging company ImaginAb. And Ra Medical Systems, maker of laser-based therapy devices, welcomes a chief commercial officer.

Appointments Commercial

Execs On The Move: New CEOs At Natera And Miach

Cell-free DNA testing technology firm Natera and bio-engineered surgical implants company Miach Orthopedics have named new CEOs this week. Natera tapped its new chief from within, while Miach brought in industry veteran Martha Shaddan to lead its Bridge-Enhanced® ACL Repair (BEAR) technology to market.

Appointments Commercial
See All
UsernamePublicRestriction

Register